1. Home
  2. SPRC vs BDRX Comparison

SPRC vs BDRX Comparison

Compare SPRC & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRC
  • BDRX
  • Stock Information
  • Founded
  • SPRC 2004
  • BDRX 2000
  • Country
  • SPRC Israel
  • BDRX United Kingdom
  • Employees
  • SPRC N/A
  • BDRX N/A
  • Industry
  • SPRC Biotechnology: Pharmaceutical Preparations
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRC Health Care
  • BDRX Health Care
  • Exchange
  • SPRC Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • SPRC 2.5M
  • BDRX 2.4M
  • IPO Year
  • SPRC N/A
  • BDRX N/A
  • Fundamental
  • Price
  • SPRC $0.22
  • BDRX $3.93
  • Analyst Decision
  • SPRC
  • BDRX Strong Buy
  • Analyst Count
  • SPRC 0
  • BDRX 1
  • Target Price
  • SPRC N/A
  • BDRX $200.00
  • AVG Volume (30 Days)
  • SPRC 675.6K
  • BDRX 381.2K
  • Earning Date
  • SPRC 02-15-2025
  • BDRX 12-27-2024
  • Dividend Yield
  • SPRC N/A
  • BDRX N/A
  • EPS Growth
  • SPRC N/A
  • BDRX N/A
  • EPS
  • SPRC N/A
  • BDRX N/A
  • Revenue
  • SPRC $1,747,000.00
  • BDRX $104,895.00
  • Revenue This Year
  • SPRC N/A
  • BDRX N/A
  • Revenue Next Year
  • SPRC N/A
  • BDRX N/A
  • P/E Ratio
  • SPRC N/A
  • BDRX N/A
  • Revenue Growth
  • SPRC N/A
  • BDRX N/A
  • 52 Week Low
  • SPRC $0.20
  • BDRX $3.50
  • 52 Week High
  • SPRC $6.78
  • BDRX $74.00
  • Technical
  • Relative Strength Index (RSI)
  • SPRC 43.97
  • BDRX 36.40
  • Support Level
  • SPRC $0.24
  • BDRX $4.14
  • Resistance Level
  • SPRC $0.29
  • BDRX $4.39
  • Average True Range (ATR)
  • SPRC 0.02
  • BDRX 0.57
  • MACD
  • SPRC -0.00
  • BDRX -0.06
  • Stochastic Oscillator
  • SPRC 9.73
  • BDRX 3.34

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Share on Social Networks: